Gs Investments, Inc. Amgen Inc Transaction History

Gs Investments, Inc.

$212 Million
Q2 2024

A detailed history of Gs Investments, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Gs Investments, Inc. holds 11,393 shares of AMGN stock, worth $3.64 Million. This represents 1.68% of its overall portfolio holdings.

Number of Shares

11,393

Previous 11,429 0.31%

Holding current value

$3.64 Million

Previous $3.25 Million 9.54%

% of portfolio

1.68%

Previous 1.57%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$262.75 - $319.31 $9,459 - $11,495	-36 Reduced 0.31%	11,393 $3.56 Million
Q1 2024 May 09, 2024	BUY	$268.87 - $324.56 $38,448 - $46,412	143 Added 1.27%	11,429 $3.25 Million
Q4 2023 Feb 08, 2024	BUY	$255.7 - $288.46 $8,949 - $10,096	35 Added 0.31%	11,286 $3.25 Million
Q3 2023 Nov 01, 2023	SELL	$218.65 - $271.46 $37,170 - $46,148	-170 Reduced 1.49%	11,251 $3.02 Million
Q2 2023 Aug 04, 2023	SELL	$214.27 - $253.37 $3,214 - $3,800	-15 Reduced 0.13%	11,421 $2.54 Million
Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $5,725 - $7,275	25 Added 0.22%	11,436 $3 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $4,713 - $5,316	-21 Reduced 0.18%	11,411 $2.57 Million
Q2 2022 Aug 03, 2022	SELL	$230.71 - $256.74 $6,921 - $7,702	-30 Reduced 0.26%	11,432 $2.79 Million
Q1 2022 Apr 26, 2022	BUY	$219.27 - $242.57 $24,119 - $26,682	110 Added 0.97%	11,462 $2.89 Million
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $17,899 - $20,484	-90 Reduced 0.79%	11,352 $2.55 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $2.43 Million - $2.85 Million	11,442 New	11,442 $2.43 Million
Q1 2021 May 07, 2021	SELL	$221.91 - $258.6 $1.4 Million - $1.63 Million	-6,290 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $1.36 Million - $1.62 Million	6,290 New	6,290 $1.45 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $2.75 Million - $3.05 Million	-11,700 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $12,462 - $15,292	-63 Reduced 0.54%	11,700 $2.76 Billion
Q1 2020 May 07, 2020	SELL	$182.24 - $241.7 $23,508 - $31,179	-129 Reduced 1.08%	11,763 $2.38 Billion
Q4 2019 Feb 04, 2020	SELL	$189.21 - $243.2 $77,765 - $99,955	-411 Reduced 3.34%	11,892 $2.2 Billion
Q3 2019 Nov 01, 2019	SELL	$174.11 - $208.62 $67,902 - $81,361	-390 Reduced 3.07%	12,303 $2.38 Billion
Q2 2019 Aug 09, 2019	BUY	$166.7 - $195.41 $55,844 - $65,462	335 Added 2.71%	12,693 $2.34 Billion
Q1 2019 Apr 26, 2019	BUY	$180.87 - $203.88 $1,808 - $2,038	10 Added 0.08%	12,358 $2.35 Billion
Q4 2018 Feb 07, 2019	BUY	$178.4 - $208.25 $2,676 - $3,123	15 Added 0.12%	12,348 $2.4 Billion
Q3 2018 Nov 06, 2018	BUY	$185.29 - $208.89 $31,684 - $35,720	171 Added 1.41%	12,333 $2.56 Billion
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $87,176 - $97,917	-525 Reduced 4.14%	12,162 $2.24 Billion
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $42,357 - $49,500	250 Added 2.01%	12,687 $2.16 Billion
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $16,035 - $17,916	95 Added 0.77%	12,437 $2.16 Billion
Q3 2017 Nov 07, 2017	BUY	$167.29 - $191.0 $6,357 - $7,258	38 Added 0.31%	12,342 $2.3 Billion
Q2 2017 Aug 29, 2017	BUY	N/A	12,304	12,304 $2.12 Billion

Others Institutions Holding AMGN

# of Institutions

3,057

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.3M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gs Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gs Investments, Inc. with notifications on news.

Account

Gs Investments, Inc. Amgen Inc Transaction History